JAMES WELSH: Open Payments
NPI 1467417386 · MIAMISBURG, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$249 in 13 payments from 5 companies in 2025. Trend: 2023 $207 · 2024 $366 · 2025 $249
Food & beverage: $249
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 8 | $156 |
| ABBVIE INC. | 2 | $38 |
| Merz Pharmaceuticals, LLC | 1 | $19 |
| Indivior Inc. | 1 | $18 |
| Abbott Laboratories | 1 | $18 |
Products named: Belbuca, UBRELVY, Xeomin, SUBLOCADE, PROCLAIM.
Industry payments across OH — which companies pay providers there.
